(SAVA) DEADLINE: Did You Suffer a Substantial Loss? Contact Johnson Fistel Regarding Leading Cassava Sciences Class Action Lawsuit
(SAVA) DEADLINE: Did You Suffer a Substantial Loss? Contact Johnson Fistel Regarding Leading Cassava Sciences Class Action Lawsuit
SAN DIEGO,Sept. 25, 2021/PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP announces that purchasers of Cassava Sciences, Inc. ("Cassava" or the "Company") (NASDAQ: SAVA) betweenSeptember 14, 2020andAugust 27, 2021, have untilOctober 26, 2021, to file a lead plaintiff motion.
聖地亞哥，2021年9月25日/PRNewswire/ — 股東權益律師事務所約翰遜·菲斯特爾律師事務所宣佈，購買者 木薯科學公司。（“木薯” 或 “公司”）（納斯達克股票代碼：SAVA）在2020年9月14日至2021年8月27日期間，必須在2021年10月26日之前提出首席原告動議。
[click here to join this action]
[點擊此處加入此行動]
According to the filed complaint: (a) the quality and integrity of the scientific data supporting Cassava's claims for simufilam's, a small molecule drug designed to treat Alzheimer's disease, efficacy had been overstated; (b) the scientific data supporting Cassava's claims for simufilam's efficacy were biased; and (c) as a result of the foregoing, Defendants' positive statements during the Class Period about the Company's business metrics and financial prospects and the likelihood of Food and Drug Administration approval were false and misleading and lacked a reasonable basis.
根據提出的申訴：（a）支持木薯聲稱的用於治療阿爾茨海默氏病的小分子藥物simufilam's的科學數據的質量和完整性被誇大了；（b）支持木薯聲稱simufilam療效的科學數據存在偏見；（c）由於上述情況，被告在集體訴訟期間對公司的積極陳述存在偏見商業指標和財務前景以及美國食品藥品監督管理局批准的可能性是虛假和誤導性的，缺乏合理的依據。
A lead plaintiff will act on behalf of all other class members in directing the Casava class-action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the class-action lawsuit. An investor's ability to share any potential future recovery of the Casava class action lawsuit is not dependent upon serving as lead plaintiff.
首席原告將代表所有其他集體成員指導Casava集體訴訟。首席原告可以選擇自己選擇的律師事務所對集體訴訟提起訴訟。投資者分享Casava集體訴訟未來可能獲得的任何賠償的能力並不取決於擔任首席原告。
If you suffered a substantial loss and are interested in learning more about being a lead plaintiff, please contactJim Baker([email protected]) by email or phone at 619-814-4471. If emailing, please include a phone number.
如果您蒙受了重大損失，並且有興趣進一步了解如何成爲首席原告，請聯繫吉姆·貝克（[電子郵件保護]) 通過電子郵件或致電 619-814-4471。如果要發送電子郵件，請附上電話號碼。
Additionally, you can [click here to join this action]. There is no cost or obligation to you.
此外，你可以 [點擊此處加入此操作]。您無需支付任何費用或義務。
AboutJohnson Fistel, LLP:
關於 Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices inCalifornia,New YorkandGeorgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.
Johnson Fistel, LLP是一家全國認可的股東權益律師事務所，在加利福尼亞州、紐約州和喬治亞州設有辦事處。該公司在股東衍生品和證券集體訴訟中代表個人和機構投資者。有關本所及其律師的更多信息，請訪問 http://www.johnsonfistel.com。律師廣告。過去的結果並不能保證未來的結果。
Contact:
聯繫人：
Johnson Fistel, LLP
Johnson Fistel，LLP
Jim Baker, 619-814-4471
吉姆·貝克，619-814-4471
[email protected]
[電子郵件保護]
SOURCEJohnson Fistel, LLPRelated Links
來源 Johnson Fistel, LLP相關鏈接
http://www.johnsonfistel.com
http://www.johnsonfistel.com
譯文內容由第三人軟體翻譯。